Celcuity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.About CELC
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.
CEOBrian F. Sullivan
CEOBrian F. Sullivan
Employees87
Employees87
HeadquartersMinneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded2012
Founded2012
Employees87
Employees87
CELC Key Statistics
Market cap397.69M
Market cap397.69M
Price-Earnings ratio-3.47
Price-Earnings ratio-3.47
Dividend yield—
Dividend yield—
Average volume191.83K
Average volume191.83K
High today$11.13
High today$11.13
Low today$9.51
Low today$9.51
Open price$11.13
Open price$11.13
Volume170.39K
Volume170.39K
52 Week high$19.77
52 Week high$19.77
52 Week low$7.58
52 Week low$7.58
CELC News
TipRanks 11h
Celcuity’s Promising Phase 3 Trial and Strong Market Position: A Buy RecommendationIn a report released today, Oliver McCammon from LifeSci Capital maintained a Buy rating on Celcuity (CELC – Research Report), with a price target of $27.00. C...
TipRanks 1d
Celcuity’s Gedatolisib Phase III Trial and Market Potential Drive Buy RatingTD Cowen analyst Tara Bancroft has maintained their bullish stance on CELC stock, giving a Buy rating on May 12. Protect Your Portfolio Against Market Uncertai...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.